Immunotherapy in treatment of cancerCancer CAR-NK therapy has an effective rate of 73%, and is being recruited in domestic clinical trials.Immunotherapy has revolutionized the way cancer is treated. ...
First immunotherapy has been approved for esophageal cancer treatment. Esophageal cancer is a common malignant tumor. The International Center for Cancer Research of the World Health Organization poi...
The University of Texas MD Anderson Cancer Center and Takeda Pharmaceutical Company Limited have entered a restrictive understanding and research consent to develop and market chimeric antigen recepto...
CAR-NK therapy is a new type of immunotherapy in the treatment of cancer treatment. Immunotherapy has revolutionized the way cancer is treated. Cancer immunotherapy is divided into two categories: on...
While working on the immune system, I accidentally discovered a new type of cell that kills most cancer. The new breakthrough can be a huge boon to cancer patients, as the newly discovered t-cell effe...
Initially depicted in 1973 by Ralph Steinman and Zanvil Cohn, dendritic cells (DCs) have a fundamental job of interfering with intrinsic insusceptible reactions and fostering a flexible immune respons...
Immune checkpoint inhibitors are a class of drugs that fight with the immune system of the body to fight cancerous cells. However, most patients do not respond to these therapies. There is a newer cla...